Efficacy and safety of nab-paclitaxel chemotherapy for patients with gastric carcinoma: A systematic review and single arm meta-analysis
Aim: This study aims to investigate the efficacy of nab-paclitaxel mono-chemotherapy as a second-line treatment for previously treated adenocarcinoma patients. Methods: We conducted a systematic review and meta-analysis of prospective single-arm clinical studies that tested nab-paclitaxel monotherap...
Main Authors: | Alyaa Khaled Madeeh, Hossam Khaled Farouk, Mohamed Mohamed Belal, Sara Ramadan, Batool Emad Al-Masri, Mohamed Samier, Salama Ahmed Gadallah, Naseba Khapoli, Abdulqadir J. Nashwan, Yossef Hassan AbdelQadir |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2024-01-01
|
Series: | Gastroenterology & Endoscopy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2949752324000025 |
Similar Items
-
Nab-paclitaxel in the treatment of breast cancer: clinical trial data and first-hand experience
by: E. I. Borisova, et al.
Published: (2018-11-01) -
nab-Paclitaxel in Combination with Carboplatin for a Previously Treated Thymic Carcinoma
by: Go Makimoto, et al.
Published: (2014-01-01) -
Study of Gemcitabine Plus Nab-Paclitaxel-Based Chemotherapy Regimen as First-Line Treatment in Metastatic Pancreatic Carcinoma
by: Kshitij Domadia, et al.
Published: (2022-01-01) -
A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer
by: Hisashi Tanaka, et al.
Published: (2017-10-01) -
Comparison of neoadjuvant nab‐paclitaxel plus immunotherapy versus paclitaxel plus immunotherapy for esophageal squamous cell carcinoma
by: Yafan Yang, et al.
Published: (2023-03-01)